Press Releases
Samsung Biologics Amplifies “Sustainable Partnership” | Highlights from 2023 BIO International Convention
At 2023 BIO International Convention in Boston, Samsung Biologics consolidated its presence as a “Sustainable Partner” by showcasing its continued commitment to sustainability with an eco-friendly booth while introducing its plans to expand the capacity and portfolio to further support its clients.
CLIENT-CENTRIC EXPANSION STRATEGY
During the week of BIO, Samsung Biologics shared plans to expedite the construction of its newest fifth plant to be operational by April 2025, with the shortest timeline of 24 months. The strategic move reflects the company’s commitment to readily support clients at any time and close the gap between the demand and supply of live-saving biomedicines.
Plant 5 adds a fresh capacity of 180,000 liters, and upon its completion, Samsung Biologics will maintain the world’s largest biomanufacturing capacity at 784,000 liters in total.
“In comparison to the same-sized Plant 3 that was operational in 35 months, we’ve been able to reduce construction time by roughly a year to set a new record,” said John Rim, CEO and President of Samsung Biologics at a press conference. “We continue to secure orders, so we have decided to speed up construction to close the gap between demand and supply.”
The new Plant 5 marks the first phase of the company’s second Bio Campus, which will house three additional plants for a total biomanufacturing capacity of 720,000 liters, as well as an Open Innovation Center for biotech incubation.
Samsung Biologics’ expansion has been made possible thanks to the continued trust and strong partnerships with clients. Plants 1 through 3 are under full utilization, while there’s been continued orders for Plant 4, the world’s largest single biomanufacturing site, which was fully complete on June 1.
“Plant 5 is designed to meet the immediate capacity needs beyond Plant 4, large volume products in the market, as well as for new opportunities, such as treatments for Alzheimer’s disease,” said Kevin Sharp, Vice President and Head of Samsung Biologics America - Sales. “Plant 5 will incorporate the knowhow and efficiencies acquired from the existing four plants to make it more effective to support client products.”
A SUSTAINABLE CDMO PARTNER
Samsung Biologics made an impact at BIO with its vibrant, eco-friendly booth, made from wood and other plastic-free materials, while brochures were downloadable via QR codes.
“Sustainability is a core component of the way we work and engage with clients,” said James Choi, Executive Vice President, Chief Marketing Officer and Head of Global Public Affairs. “By moving towards more sustainable alternatives at every level of our business, even events, we’re standing behind our commitment to decarbonize and achieve net zero by 2050 or earlier.”
The booth had a large display playing the Samsung Biologics’ new branding video for Plant 5 and BIO Campus II to give visitors a better understanding of the new facilities. It also showcased the company’s capabilities in CMO, CDO, mRNA, ADC and sustainability.
The Samsung Biologics team also actively used the convention to engage with existing and potential clients for future development and manufacturing projects, while the company co-hosted the main reception event for key clients and BIO visitors for networking.
“The BIO conference is really important for us – we have a large presence and we have an amazing booth where people stop by to see and learn about our facilities,” said Eric Hsu, Head of Key Account Management Sales Execution Group. “We’ve met with a lot of people, both current clients and expected clients, so it’s really important that we do this to help the growth of the company, share our capabilities and future services.”
Samsung Biologics will continue to leverage its unparalleled experience and expertise to add unbeatable value to our existing services and deliver long-term success for clients.
Related Content
Press Release Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025
At 2023 BIO International Convention in Boston, Samsung Biologics consolidated its presence as a “Sustainable Partner” by showcasing its continued commitment to sustainability with an eco-friendly booth while introducing its plans to expand the capacity and portfolio to further support its clients.
CLIENT-CENTRIC EXPANSION STRATEGY
During the week of BIO, Samsung Biologics shared plans to expedite the construction of its newest fifth plant to be operational by April 2025, with the shortest timeline of 24 months. The strategic move reflects the company’s commitment to readily support clients at any time and close the gap between the demand and supply of live-saving biomedicines.
Plant 5 adds a fresh capacity of 180,000 liters, and upon its completion, Samsung Biologics will maintain the world’s largest biomanufacturing capacity at 784,000 liters in total.
“In comparison to the same-sized Plant 3 that was operational in 35 months, we’ve been able to reduce construction time by roughly a year to set a new record,” said John Rim, CEO and President of Samsung Biologics at a press conference. “We continue to secure orders, so we have decided to speed up construction to close the gap between demand and supply.”
The new Plant 5 marks the first phase of the company’s second Bio Campus, which will house three additional plants for a total biomanufacturing capacity of 720,000 liters, as well as an Open Innovation Center for biotech incubation.
Samsung Biologics’ expansion has been made possible thanks to the continued trust and strong partnerships with clients. Plants 1 through 3 are under full utilization, while there’s been continued orders for Plant 4, the world’s largest single biomanufacturing site, which was fully complete on June 1.
“Plant 5 is designed to meet the immediate capacity needs beyond Plant 4, large volume products in the market, as well as for new opportunities, such as treatments for Alzheimer’s disease,” said Kevin Sharp, Vice President and Head of Samsung Biologics America - Sales. “Plant 5 will incorporate the knowhow and efficiencies acquired from the existing four plants to make it more effective to support client products.”
A SUSTAINABLE CDMO PARTNER
Samsung Biologics made an impact at BIO with its vibrant, eco-friendly booth, made from wood and other plastic-free materials, while brochures were downloadable via QR codes.
“Sustainability is a core component of the way we work and engage with clients,” said James Choi, Executive Vice President, Chief Marketing Officer and Head of Global Public Affairs. “By moving towards more sustainable alternatives at every level of our business, even events, we’re standing behind our commitment to decarbonize and achieve net zero by 2050 or earlier.”
The booth had a large display playing the Samsung Biologics’ new branding video for Plant 5 and BIO Campus II to give visitors a better understanding of the new facilities. It also showcased the company’s capabilities in CMO, CDO, mRNA, ADC and sustainability.
The Samsung Biologics team also actively used the convention to engage with existing and potential clients for future development and manufacturing projects, while the company co-hosted the main reception event for key clients and BIO visitors for networking.
“The BIO conference is really important for us – we have a large presence and we have an amazing booth where people stop by to see and learn about our facilities,” said Eric Hsu, Head of Key Account Management Sales Execution Group. “We’ve met with a lot of people, both current clients and expected clients, so it’s really important that we do this to help the growth of the company, share our capabilities and future services.”
Samsung Biologics will continue to leverage its unparalleled experience and expertise to add unbeatable value to our existing services and deliver long-term success for clients.
Related Content
Press Release Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025